Assante, G., Chandrasekaran, S., Ng, S., Tourna, A., Chung, C. H., Isse, K. A., … Youngson, N. A. (2023). Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease. Genome Med, 15(1), 38. https://doi.org/10.1186/s13073-023-01190-7

Assante, Gabriella, Sriram Chandrasekaran, Stanley Ng, Aikaterini Tourna, Carolina H. Chung, Kowsar A. Isse, Jasmine L. Banks, et al. “Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease.” Genome Med 15, no. 1 (May 18, 2023): 38. https://doi.org/10.1186/s13073-023-01190-7.

Assante G, Chandrasekaran S, Ng S, Tourna A, Chung CH, Isse KA, et al. Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease. Genome Med. 2023 May 18;15(1):38.

Assante, Gabriella, et al. “Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease.” Genome Med, vol. 15, no. 1, May 2023, p. 38. Pubmed, doi:10.1186/s13073-023-01190-7.

Assante G, Chandrasekaran S, Ng S, Tourna A, Chung CH, Isse KA, Banks JL, Soffientini U, Filippi C, Dhawan A, Liu M, Rozen SG, Hoare M, Campbell P, Ballard JWO, Turner N, Morris MJ, Chokshi S, Youngson NA. Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease. Genome Med. 2023 May 18;15(1):38.